Voyager Therapeutics is trading 5.78% up at $3.66, with no clear company-specific catalyst identified for August 28, 2026.
- Latest identifiable company disclosures were second-quarter results filed August 6 and an August 21 investor event, rather than a new overnight announcement.
- Major U.S. indices were broadly flat pre-market, and recent company coverage offered no direct explanation.
- The catalyst remains unconfirmed; follow-up checking is warranted.